NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III Sells 1,604 Shares

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 1,604 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $7.06, for a total value of $11,324.24. Following the transaction, the chief executive officer now owns 184,717 shares of the company’s stock, valued at $1,304,102.02. This trade represents a 0.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

George Lawrence Mikan III also recently made the following trade(s):

• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total value of $70,236.54.

NeueHealth Stock Performance

Shares of NEUE opened at $6.77 on Thursday. The stock has a 50-day simple moving average of $7.32 and a 200-day simple moving average of $5.99. The stock has a market capitalization of $56.09 million, a PE ratio of -0.13 and a beta of 0.56. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $7.73.

Hedge Funds Weigh In On NeueHealth

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC purchased a new position in shares of NeueHealth in the 4th quarter valued at about $76,000. Northern Trust Corp boosted its stake in shares of NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after buying an additional 13,074 shares during the period. Finally, Partners Group Holding AG purchased a new position in shares of NeueHealth in the 3rd quarter valued at about $463,000. Hedge funds and other institutional investors own 63.88% of the company’s stock.

Analysts Set New Price Targets

Separately, Royal Bank of Canada decreased their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research note on Monday, December 9th.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.